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ABSTRACT  
Rationale and Aim 
The structures and processes around the management of medicines for elderly, 
hospitalised patients are ill defined. This study aimed to determine consensus related to 
strategic and operational approaches in the Unites Arab Emirates. 
Methods 
A modified Delphi technique, consensus study with first round statements developed 
from systematic reviews related to medicines management. Normalization Process 
Theory and the Theoretical Domains Framework were applied in the construction of 
statements, organised into key elements of medicines management: guidelines for 
medicines management; medicines reconciliation; medicines selection, prescribing and 
review; medicines adherence; medicines counselling; health professional training; and 
evaluation research. 70% (summative agree and strongly agree) was set as the target 
for consensus. Thirty panellists were recruited representing: senior physicians working 
within geriatrics; hospital pharmacy and nursing directors; chief health professionals 
(including social workers) and policy makers within the Health Authority of Abu Dhabi; 
and academics.  
Results 
A high level of consensus was obtained for most statements relating to the structures 
and processes of medicines management. While consensus was not achieved for 
targeting only those patients with medicines related issues, it was achieved for focusing 
on all elderly admissions. Similarly, consensus was not achieved for which professions 
were most suited to roles, but was achieved for trained and competent staff. 
Conclusions 
High levels of consensus were obtained for structures and processes of medicines 
management relating to elderly hospitalised patients. Trained and competent health 
professionals were preferred to specific professions for any tasks and that all elderly 
patients and not targeted patients should be the focus for medicines management.  
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INTRODUCTION 
Donabedian proposed a conceptual framework for health services and quality of care, 
describing elements of structures, processes and outcomes, which could be applied in all 
healthcare settings and at all levels.[1] Structures are the characteristics of the care 
setting, including: attributes of material resources (e.g. facilities, equipment); human 
resources (e.g. number of qualified personnel) and of organisational structure (e.g. 
methods of peer review, methods of reimbursement). Processes detail what is carried 
out as part of giving care (e.g. practitioner’s activities in making a diagnosis, 
recommending treatment, or other interactions with the patients). Outcomes attempt to 
describe the patients’ resultant status of health.   
Elderly patients (defined commonly as those aged 65 years and over) are at particular 
risk of medicines related issues occurring throughout the hospital journey from 
admission to discharge. These issues may be due, in part, to inappropriate 
polypharmacy (prescribing of many medicines which are either inappropriate or no 
longer indicated).[2] This is considered to be ‘one of the greatest prescribing challenges’, 
increasing the likelihood of adverse drug reactions and drug interactions, complicating 
patient monitoring and contributing to patient non-adherence.[3] Data from the United 
Kingdom (UK) highlight that on fifth of patients with two clinical conditions were 
receiving four to nine medicines, and one tenth receiving ten or more medicines. These 
figures increased to around half in those with six or more comorbidities.[4] Related UK 
data stress the issue of medicines related adverse effects, contributing to over 1.5 
million extra hospital bed-days annually.[5] Non-adherence to prescribed medicines is a 
major issue, with research suggesting that between half and three quarters of those 
patients with chronic conditions may be non-adherent.[6] Medicines related issues in the 
elderly may occur during process of medicines reconciliation at admission, prescribing 
and monitoring during stay, medicines counselling and information transfer at discharge. 
It is therefore important that the structures and processes of medicines management are 
clearly described to optimise patient outcomes. While there is no globally accepted 
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definition of the term ‘medicines management’, one of the most commonly cited is that 
of the United Kingdom Audit Commission, encompassing ‘the entire way that medicines 
are selected, procured, delivered, prescribed, administered and reviewed to optimise the 
contribution that medicines make to producing informed and desired outcomes of patient 
care’.[7] Several systematic reviews provide evidence to guide some of the processes 
related to medicines management, relating to medicines reconciliation,[8,9] tools to 
identify inappropriate prescribing and high risk drugs,[10] and medicines adherence, 
[11] however none cover the full spectrum of activities during the patient journey and 
several have highlighted the paucity and general poor quality of the literature and the 
lack of translation of evidence into practice.  
The United Arab Emirates (UAE) comprises seven emirates: Abu Dhabi, Dubai, Ajman, 
Fujairah, Sharjah, Ras al-Khaimah, and Umm al-Qaywayn. The UAE vision 2021 states 
that hospitals will be accredited to ‘clear national and international quality standards of 
medical services and staff’.[12] Healthcare is planned, delivered and regulated through 
three geographical zones: the southern zone comprising Abu Dhabi with The Health 
Authority of Abu Dhabi (HAAD) as the regulatory body; the central zone of Dubai, under 
the auspices of the Dubai Health Authority; and the north Emirates or the northern zone 
under the Ministry of Health. There are no guidelines for medicines management of 
elderly hospitalised patients (or any other patient group) and qualitative interviews with 
health professionals identified a need for a more structured approach.[13] 
The primary aim of this phase of the research was to determine consensus of an expert 
panel in relation to strategic and operational approaches around medicines management 
for elderly, hospitalised patients in the UAE. The secondary aim was to determine 
panellists’ views on the use of the consensus method.  
METHODS 
Research design 
A consensus based, quantitative approach was employed with the overall aim of 
generating consensus among the participants. The three main approaches are the Delphi 
technique, the Nominal Group technique and the Consensus Development technique.[14-
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16] Essentially, consensus methods utilize a group of experts in a particular field to 
gather evidence.[17] These approaches are particularly suited to the development of 
professional norms and areas of practice where published evidence is lacking. In these 
situations, there will undoubtedly be potential for diverse personal and subjective 
opinions that need to be considered. Consensus methods attempt to systematically and 
objectively gather, organise and synthesise this diversity in an attempt to provide a 
single consensus. 
The modified Delphi technique  
A modified Delphi technique was selected for this study for several reasons. Unlike the 
other approaches, it avoids the need for face to face meetings which can be difficult to 
organise, particularly over large geographical areas such as the UAE. Furthermore, the 
Delphi technique maintains participant anonymity at all stages and removes the 
influence of highly dominant participants and the pressure to conform.[18] The Delphi is 
a group communication process which is operationalised via a structured, isolated, 
iterative method of repetitive administration of questionnaires across a number of 
rounds.[19,20] 
Key features of the Delphi technique are: identifying the participants (expert panel 
members); anonymity; structured data collection questionnaires; feedback to expert 
panel members allowing them to reflect and reconsider their responses; and statistical 
aggregation of responses.[19,20] This study employed the modified Delphi technique in 
that the first round was not the traditional qualitative enquiry to generate statements 
and also only one round was conducted. 
Setting 
This research was conducted within Abu Dhabi, the largest emirate in the UAE, with the 
highest rate of healthcare expenditure and more established governance systems than 
the other emirates. 
Delphi statements   
The statements for the first round of the Delphi were developed from a review of 
systematic literature reviews related to medicines management,[8-10] and policy 
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guidance statements.[21] Statements were developed and organised into key elements 
of the medicines management model: guidelines for medicines management in elderly 
hospitalised patients; medicines reconciliation; medicines selection, prescribing and 
review; medicines adherence; medicines counselling; health professional training; and 
evaluation research.  
Two theoretical frameworks were applied in the construction of the Delphi statements, 
Normalization Process Theory (NPT) and the Theoretical Domains Framework (TDF). NPT 
explains ‘…the social processes through which new or modified practices of thinking, 
enacting and organising work are operationalised in healthcare and other 
institutionalised settings’.[22] The theory proposes that: 
1. practices become routinely embedded in social contexts as the result of people 
working, individually and collectively, to implement them; 
2. the work of implementation is operationalised through four generative mechanisms or 
constructs of: coherence; cognitive participation; collective action; and reflexive 
monitoring; 
3. the production and reproduction of a practice requires continuous investment.[22,23] 
NPT was applied to develop statements in terms of coherence (definitions of key 
elements of medicines management), cognitive participation (task allocation of the 
responsibilities of health professionals), collective action (the actual work or skills 
involved in delivering the tasks) and reflexive monitoring (specialised education and 
training services).  
TDF is a framework of theories of behaviour change which aims to ‘…simplify and 
integrate a plethora of behaviour change theories and make theory more accessible to, 
and usable by, other disciplines’.[24] TDF was derived from 33 psychological theories 
and 128 theoretical constructs organised into 14 overarching domains (e.g. knowledge, 
beliefs of consequences, social influences etc.).[24,25] 
The statements were tested for face and content validity by a panel of seven key 
individuals in the fields of medicines management, healthcare processes, behaviour 
change and research, based in Scotland and the UAE. These individuals, identified from 
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professional networks, were emailed the statements with instructions to comment on 
clarity and appropriateness. Responses allowed further refinements of the statements in 
terms of wording, sequencing and some additional statements were suggested.  
Determining consensus  
The following six-point Likert scale was used for each statement: strongly disagree; 
disagree; somewhat disagree; somewhat agree; agree; and strongly agree. The 
approaches described in the literature for determining the point of consensus include: a 
stipulated number of rounds; subjective analysis; certain level of agreement; average 
percent of majority opinions cut-off rate; mode, mean, median ratings and rankings; 
interquartile range; coefficient of variation; and post-group consensus.[26] The ‘certain 
level of agreement’ was adopted in this study and while it has been highlighted that 
there is no set standard for the target percentage of agreement,[27] 70% (summative 
agree and strongly agree) was set as the target as commonly employed in other 
studies.[25]  
Expert panel members 
The careful selection of participants as ‘expert panel members’ is an essential step to 
provide robust and valid data. Panellists should represent the key stakeholders, experts 
in the field, and policy and decision makers.[28] Delphi study findings are considered to 
be more valid if panellists are recruited from heterogeneous groups and, while there is 
no clear guidance on the number of panellists, it is argued that minimal change in 
reliability of findings is likely beyond 30 members.[26-28] 
In this study, panellists were recruited from: all 18 public hospitals in Abu Dhabi which 
had been authorized by HAAD to conduct research on human subjects; HAAD; and Al Ain 
Medical University. The sampling frame included targeted strategic health practitioner 
leads, decision aid developers and researchers, policy makers, as these would have the 
required knowledge, experience and policy influence. These were: senior physicians 
working within the geriatric speciality, or those with ten years or more experience in 
managing elderly patients; hospital pharmacy and nursing directors; chief health 
professionals (nurses, pharmacists, physicians) holding strategic positions within HAAD; 
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chief policy makers in hospitals or HAAD; chief social workers in hospitals or HAAD; and 
senior educators or researchers in Al Ain Medical School. The sampling frame was 
estimated to be around 75 health professionals and 25 other professionals. While patient 
group experts would be included in countries such as the United Kingdom, the 
philosophy of involving patients in strategic decision making in the UAE is in its infancy 
hence patients were not included.  
Recruitment of panellists 
A snowball sampling approach was employed with the principal investigator having face 
to face meetings with: the senior physician for geriatrics, directors of pharmacy and 
nursing in one hospital; the manager for clinical reviews and investigations at HAAD; and 
a university professor. The study requirements were discussed, each provided with an 
email invitation and participant information leaflet, requesting that they forwarded this 
to others meeting the criteria as described in Table 1.  
Insert table 1 here  
 
 
Informed consent was obtained from each panellist once they had accepted the 
invitation to participate.  
Delphi rounds 
At the point of study commencement, each panellist was sent an email with a link to the 
online questionnaire which had been formatted using SNAP 10 (an integrated software 
package used to design surveys for printing or publishing on the web). Data generated 
from online surveys using SNAP can be transferred directly into SPSS for analysis. 
Delphi round 1  
The round 1 questionnaire was structured into eight sections covering key elements of 
medicines management, each with several statements. Panellists were requested to rate 
their levels of agreement or disagreement with each statement on the 6-point Likert 
scale. A comments box was included for each statement, allowing justification of 
responses and proposing new statements. A three week deadline was given for 
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completion and return of round 1. Descriptive statistics (frequencies and percentages) 
were used to analyse responses. Content analysis was undertaken for textual responses 
to identify any emerging themes.[29]  
Delphi round 2 
Each panellist was provided with the summary responses for each statement, the 
verbatim panellists’ comments for each statement and any comments from the research 
team. Due to the level of consensus achieved, the second round provided an opportunity 
to gathering panellists’ views and experiences of the Delphi approach and its potential 
uses in the UAE.  
A separate survey tool was developed, consisting of a series of statement to be rated 
using a semantic differential scale which required panellists’ to choose a response 
between two bipolar options (e.g. ‘easy’ and ‘difficult’). A three week deadline was given 
to panellists for completion of round 2. Descriptive categorical statistics (median, 
interquartile range (IQR)) were used for analysis.  
Research ethics  
Approval was obtained from the ethical review panel of the School of Pharmacy and Life 
Sciences at Robert Gordon University and from HAAD.  
RESULTS 
Round 1 
Responses were received from 26 panellists (86.7%); two directors of nursing, one 
family physician and one public health advisor did not respond. Responses to the round 
one statements on general aspects and guidelines for medicines management are given 
in Table 2. Consensus was achieved for all statements other than that relating to 
targeting medicines management activities only to those admitted with medicines related 
issues. 
 
Insert table 2 here 
Responses relating to medicines reconciliation and medicines review are given in Table 3. 
While consensus was not achieved that medicines reconciliation could be undertaken by 
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any nurse, pharmacist or physician, it was achieved that it should only be undertaken by 
a health professional trained in that role. Similar responses were received in relation to 
the health profession which should undertake medicines review. Consensus was not 
achieved for that only elderly patients admitted with a medicines related issue should 
have a full medicines review.  
 
Insert table 3 here 
 
 
Responses relating to medicines adherence and counselling are given in Table 4. While 
consensus was not achieved that determination of medicines adherence could be 
undertaken by any nurse, pharmacist or physician, it was achieved that it should only be 
undertaken by a health professional trained in that role. Similar responses were received 
in relation to the health profession which should undertake medicines counselling. 
Consensus was not achieved that counselling should be targeted but should be provided 
to all. Few comments were provided by the panellists in round one, and there was a 
notable absence of comments from those disagreeing. No new statements were 
suggested.  
 
Insert table 4 here 
 
 
Responses relating to training and evaluation research are given in Table 5. Consensus 
was reached for all statements.  
 
Insert table 5 here 
 
Round 2 
During round 2, panellists were provided with the detailed results of round 1, 
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highlighting most of statements achieving consensus agreement (≥70%). While 20 
statements did not reach consensus, the decision was taken to not repeat a further 
round attempting to gain consensus for these 20. It was considered that the responses 
to those statements achieving consensus themselves explained those not achieving 
consensus. For example, while consensus was achieved that all elderly patients should 
be a focus for medicines management, it was not achieved for only targeted patients. 
The second round therefore focused on panellists’ views and experiences of the Delphi 
approach and its potential uses in the UAE. 
The response rate was 83% (n=25). Eighty-four percent (n=21) of panellists were not 
previously aware of consensus methods and only 8% (n=2) had prior experience of 
being involved in a consensus study. Views were generally positive in relation to their 
involvement in the study and the potential to use this approach in further service 
developments. Table 6 gives detailed responses.  
 
Insert table 6 here 
 
DISCUSSION 
Key findings are that a high level of consensus was obtained for most statements 
relating to the structures and processes of medicines management for elderly 
hospitalised patients. While consensus was not achieved for targeting only those patients 
with medicines related issues, it was achieved for focusing on all elderly admissions. 
Similarly, consensus was not achieved for which professions were most suited to roles 
but was achieved that those delivering the roles should be trained. Panellists were 
positive about the Delphi study and its potential to be employed in further health related 
developments. While few panellists had prior experience of consensus methods, almost 
all rated their experience positively and would consider this in future health related 
developments.  
Strengths and limitations  
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Strengths of this study include grounding the statements in evidence derived from 
systematic reviews and previous research, and use of two recognised theoretical 
frameworks of behavioural change, and intervention development, implementation and 
sustainability.[8-10, 13, 22-25]. Furthermore the panellists represented a heterogeneous 
group of key stakeholders, increasing the likelihood of internal validity, and a high 
response rate was obtained throughout the Delphi, increasing generalisability.  
However, there are study limitations and hence the findings should be interpreted with 
caution. The cut off value for consensus of agreement was rather arbitrary with no set of 
standard, although this is one of the most widely used approaches.[26,27] For those 
statements which had levels of agreement over 90%, several panellists strongly 
disagreed, indicating diametrically opposite views, which could reduce the internal 
validity. Due to the method of data collection, it was not possible to identify any of the 
respondents or to match response items and it may have been that the same individuals 
or types of individuals were disagreeing with the statements. This could have 
implications for implementing study findings. There was also a notable absence of 
comments to explain responses, particularly from those disagreeing with the statements. 
Moreover, though the study was unique in its focus on the UAE, its generalisability may 
be questionable due to cultural and conceptual differences.[30] It is, however, likely that 
the approach used in this study, the use of the theoretical models and most importantly, 
the findings, will be applicable globally.  
Interpretation of findings 
Responses to statements are in line with the concept of clinical governance, ‘a system 
through which organisations are accountable for continuously improving the quality of 
their services and safeguarding high standards of care by creating an environment in 
which excellence in clinical care will flourish’.[31] Responses highlight the need for 
trained staff to deliver high quality service supported by standard operating procedures 
and clearly documented audit trails. 
Only a few previous studies have used a consensus approach to any aspect of medicines 
management, around rational prescribing in Iran,[32] medicines reconciliation in the 
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United States,[33] patient non-adherence in Europe,[34] and minimising inappropriate 
prescribing in the elderly in Europe.[35 Results highlighted a degree of consensus around 
processes of medicines management and the need to clearly define processes and 
allocate tasks. Our study provided definitions of ‘medicines management’, ‘medicines 
reconciliation’, ‘medicines review’, ‘appropriate polypharmacy’ and ‘medicines 
counselling’ in an attempt to promote coherence and shared beliefs of health 
professionals in relation to these processes; importantly high levels of consensus were 
obtained for all. Panellist responses also indicated that all elderly patients admitted to 
hospital should receive the same focus on medicines management, irrespective of the 
reason for admission. There may, however, be resource implications in delivering such a 
service (i.e. the entire medicines management model including determining adherence 
and medicines review) for all irrespective of the reason for admission or planned 
duration. Key aspects of NPT are cognitive participation and collective action with clearly 
defined and agreed task and task allocation. Interestingly, consensus was not achieved 
for which health professions should deliver tasks such as medicines reconciliation, review 
and counselling, preferring to agree that those delivering the role should be trained and 
hence competent. This would go some way to avoiding task omission or task duplication 
in these areas, which was identified in recent qualitative work.[13] The expressed need 
for research evaluation to monitor the effect of medicines management guidelines, task 
allocation, standard operating procedures and standards of documentation was evident 
and reassuring. This aligns to the NPT construct of reflexive monitoring which is more 
likely to result in sustainable, patient centred processes resulting in desired outcomes 
with enhanced patient safety.[22,23] It is essential that this focus on medicines 
management is continued as patients are discharged into primary care (and beyond) 
given the multitude of evidence of medicines related issues at the point of patient 
transfer and that these can be reduced by medicines reconciliation.[8,9,36] Further 
research will focus on developing the guidelines, with an advisory group of panellists and 
practitioners, and pilot testing these with evaluation from the perspectives of health 
professionals, managers, leaders ad patients prior to full scale implementation. Emphasis 
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needs to be placed on the economic consequences of guidelines and the impact on 
patients not covered by the guideline. 
Conclusion 
High levels of consensus were obtained for structures and processes of medicines 
management relating to elderly hospitalised patients. Trained and competent health 
professionals were preferred to specific professions for any tasks and that all elderly 
patients and not targeted patients should be the focus for medicines management.  
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Table 1: Delphi panellists (N=30) 
Panellists Number 
Physician (geriatrics) 3 
Physician (family) 3 
Hospital pharmacy directors 5 
Hospital nursing directors 5 
Manager for clinical reviews and 
investigations (HAAD) 
1 
Medical advisor (HAAD) 2 
Director of public health (HAAD) 1 
Public health advisor (HAAD) 1 
Policy maker (HAAD) 2 
Chief social worker (HAAD) 2 
Senior academics at medical faculty 5 
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Table 2 – Responses relating to general comments and guidelines for medicines 
management (N=26) 
Statements 
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The following definition of medicines management 
should be adopted in the UAE - ‘the clinical, safe 
and cost effective use of medicines to ensure 
patients get the maximum benefit from the 
medicines they need, while at the same time 
minimizing potential harm’ 
4    6 16 85 
Elderly patients with multi-morbidities are at 
particular risk of medicines related issues 
2    7 17 92 
Medicines management should be a focus in the 
care of every elderly patient admitted to hospital, 
irrespective of the reason for admission or 
presenting complaint 
2   1 7 16 88 
Medicines management should be a focus in the 
care of every elderly patient admitted to hospital, 
irrespective of the admitting ward or speciality 
2    8 16 92 
Medicines management should be a focus in the 
care of elderly patient admitted to hospital, 
irrespective of the duration of stay in hospital 
2   3 7 14 81 
Medicines management should only be a focus in 
the care of elderly patients admitted to hospital with 
a medicines related issue 
10 5  2 5 4 35 
Medicines management is the responsibility of all 
nurses, pharmacists and physicians 
1   3 3 19 85 
All nurses, pharmacists, physicians should be 
competent in medicines management 
1   1 9 15 92 
Evidence based recommendations which focus on 
single disease states should be applied with caution 
in elderly patients with multi-morbidities 
1   1 8 16 92 
There is a need to develop guidelines for medicines 
management in elderly hospitalised patients in the 
UAE 
2   1 7 16 88 
A guideline development group should be 
established, under the auspices of HAAD, with 
representation from experts in medicines in the 
elderly 
2  1 1 9 13 85 
The guidelines should have a focus on medicines 
reconciliation at the point of admitting and 
discharging elderly patients to hospital 
2   1 8 15 88 
The guidelines should have a focus on the 
prescribing of medicines in the elderly 
2    11 13 92 
The guidelines should have a focus on the 
monitoring of medicines in the elderly 
1    10 15 96 
The guidelines should have a focus on managing 
inappropriate polypharmacy in elderly patients with 
multi-morbidities. (Inappropriate polypharmacy is 
1 1   10 14 92 
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defined as ‘the prescribing of too many medicines 
which are unsuitable or no longer indicated’) 
The guidelines should have a focus on reviewing all 
medicines in elderly patients with multi-morbidities 
to promote appropriate polypharmacy (Appropriate 
polypharmacy is ‘prescribing of many medicines but 
which are suitable’) 
    9 17 100 
The guidelines should highlight high risk medicines 
in the elderly 
1    7 18 96 
The guidelines should highlight potentially 
inappropriate medicines in the elderly 
1 1  1 6 16 88 
Consideration should be given to adapting defined 
lists of high risk or potentially inappropriate 
medicines in the elderly, for the UAE context, such 
as: Beers Criteria; STOPP Criteria; IPET 
1 1   12 12 92 
The guidelines should have a focus on identifying 
and managing adverse drug reactions in the elderly 
1  1 1 9 14 88 
Consideration should be given to adapting defined 
list of commonly omitted medicines in the elderly, 
for the UAE context, such as: START Criteria  
1 1  4 7 13 77 
Consideration should be given to adopting validated 
measures of adherence, such as: Morisky scale; 
Medication adherence questionnaire; Self-Efficacy 
for Appropriate Medication Use Scale 
 1  4 7 14 81 
The guidelines should have a focus on adherence 
(or non-adherence) to medicines 
1 1  3 10 11 81 
Consideration should be given to adopting evidence 
based approaches to guideline implementation in 
the UAE 
   2 10 14 92 
*summative percentage of respondents agreeing or strongly agreeing 
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Table 3– Responses relating to medicines reconciliation and medicines review (N=26) 
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The following definition of medicines reconciliation 
should be adopted in the UAE - ‘the process of 
identifying the most accurate list of a patient’s 
current medicines – including the name, dosage, 
frequency and route – and comparing them to the 
current list in use, recognizing and discrepancies, 
and documenting any changes, thus resulting in a 
complete list of medications, accurately 
communicated’ 
1   2 11 12 88 
Medicines reconciliation should be determined at the 
point of admission to and discharge from hospital 
1    9 16 96 
Determination of medicines reconciliation can be 
undertaken by any nurse, pharmacist, physician 
1 5 4 7 5 4 35 
Determination of medicines reconciliation can be 
undertaken by any nurse 
5 6 6 5 2 2 15 
Determination of medicines reconciliation can be 
undertaken by any pharmacist 
1 3 3 7 6 6 46 
Determination of medicines reconciliation can be 
undertaken by any physician 
1 3 3 4 8 7 58 
Determination of medicines reconciliation should 
only be undertaken by a health professional trained 
in that role 
 2 3 2 9 10 73 
Determination of medicines reconciliation in an 
elderly patient with dementia or other cognitive 
impairment requires specialist input 
 1  1 12 12 92 
Any medicines related issues resulting from 
determination of medicines reconciliation should be 
recorded in the shared medical records 
   2 9 15 92 
There is a need for a standard operating procedure 
to guide the determination of medicines 
reconciliation in elderly patients 
1  1  9 15 92 
There is a need to develop standardised 
documentation to record determination of medicines 
reconciliation in elderly patients 
 2   7 17 92 
The following definition of medicines review should 
be adopted in the UAE  - ‘a structured, critical 
examination of the complete list of a patient's 
medicines with the objective of reaching an 
agreement with the patient about treatment, 
optimising the impact of medicines, minimising the 
number of medication-related problems and 
reducing waste’ 
  1 1 16 8 92 
All elderly patients with multi-morbidities should 
have a full medicines review during their stay in 
hospital to promote appropriate polypharmacy 
 1  2 8 15 88 
Only elderly patients admitted with a medicines 
related issue should have a full medicines review 
during their stay in hospital to promote appropriate 
6 5 5 2 6 2 31 
23 
 
polypharmacy 
A full medicines review can be undertaken by any 
nurse, pharmacist, physician 
3 8 5 1 6 3 35 
A full medicines review can be undertaken by any 
nurse 
10 3 10  3  12 
A full medicines review can be undertaken by any 
pharmacist 
2 5 2 5 4 8 46 
A full medicines review can be undertaken by any 
physician 
2 3 3 4 9 5 54 
A full medicines review should only be undertaken 
by a health professional trained in that role 
2 1 1 3 7 12 73 
A full medicines review in an elderly patient with 
dementia or other cognitive impairment requires 
specialist input 
1 1 1  9 14 88 
Any medicines related issues resulting from a full 
medicines review should be recorded in the shared 
medical records 
 1 1  8 16 92 
There is a need for a standard operating procedure 
to guide the conduct of a full medicines review in 
elderly patients 
  1  10 15 96 
There is a need to develop standardised 
documentation to record a full medicines review in 
elderly patients 
  1 1 8 16 92 
A multi-disciplinary ward team (specifically nurses, 
pharmacists and physicians) should review the 
medicines prescribed to elderly patients on a regular 
basis during their stay in hospital 
  1 3 6 16 85 
All medicines prescribed to elderly patients during 
stay in hospital should be reviewed prior to their 
discharge 
  1  9 16 96 
The standard operating procedure should include 
providing information to health professionals (family 
doctor, nurse, pharmacist) working in primary care 
informing them of the nature of any changes made 
to medicines during stay and any follow-up required 
  1  9 16 96 
*summative percentage of respondents agreeing or strongly agreeing 
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Table 4 – Responses relating to medicines adherence and counselling (N=26) 
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The following definition of medicines adherence 
should be adopted in the UAE - ‘the extent to which 
patients take medicines as prescribed by their 
health care providers’ 
1   1 13 11 92 
Adherence (or non-adherence) to all medicines 
should be determined at   the point of admitting all 
elderly patients to hospital 
2 1  4 9 10 73 
Determination of adherence (or non-adherence) can 
be undertaken by any nurse, pharmacist, physician 
1 4 3 8 6 4 38 
Determination of adherence (or non-adherence) can 
be undertaken by any nurse 
3 5 1 10 6 1 27 
Determination of adherence (or non-adherence) can 
be undertaken by any pharmacist 
1 2 2 5 9 7 62 
Determination of adherence (or non-adherence) can 
be undertaken by any physician 
2 2 1 5 11 5 62 
Determination of adherence (or non-adherence) 
should only be undertaken by a health professional 
trained in that role 
2 1 1 1 14 7 81 
Determination of adherence (or non-adherence) in 
an elderly patient with dementia or other cognitive 
impairment requires specialist input 
1  2 3 9 11 77 
Any medicines related issues resulting from 
determination of adherence should be recorded in 
the shared medical records 
  1  11 14 96 
There is a need for a standard operating procedure 
to guide the determination of adherence (or non-
adherence) in elderly patients 
1  3 1 6 15 81 
There is a need to develop standardised 
documentation to record determination of 
adherence (or non-adherence) in elderly patients 
1  2  7 16 88 
The following definition of medicines counselling 
should be adopted in the UAE - ‘provision of advice 
and instruction by a health care professional to 
patients regarding the appropriate use of their 
medicines’ 
1  1 1 8 15 88 
All elderly patients should be counselled on their 
medicines prior to discharge 
  1  8 17 96 
Only elderly patients identified as non-adherent/ 
potentially non-adherent should be targeted for 
counselling on their medicines prior to discharge 
4 7 4 1 5 5 38 
Only elderly patients commenced new medicines or 
having a change in medicines should be targeted for 
counselling on their medicines prior to discharge 
5 8 2 2 8 1 35 
Medicines counselling can be undertaken by any 
nurse, pharmacist, physician 
5 6 4 4 5 2 27 
Medicines counselling can be undertaken by any 
nurse 
6 8 7 3 1 1 8 
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Medicines counselling can be undertaken by any 
pharmacist 
2 2 2 5 6 9 58 
Medicines counselling can be undertaken by any 
physician 
2 6 1 5 8 4 46 
Medicines counselling should only be undertaken by 
a health professional trained in that role 
2 1 1 3 9 10 73 
Medicines counselling in an elderly patient with 
dementia or other cognitive impairment requires 
specialist input 
  1 2 11 12 88 
Medicines counselling should always involve the 
elderly patient’s family/carers/friends where 
appropriate 
1  1 1 7 16 88 
Counselling should focus on elderly patients’ beliefs, 
intentions and values relating to medicines to 
encourage behavioural and lifestyle changes 
1  1 3 9 12 81 
There is a need for a standard operating procedure 
to guide medicines counselling in elderly patients 
1  2 1 6 16 85 
The standard operating procedure should include 
providing information to health professionals (family 
doctor, nurse, pharmacist) working in primary care 
informing them of the nature of any counselling 
provided prior to discharge and any follow-up 
support required 
   1 10 15 96 
There is a need to develop standardised 
documentation to record counselling in elderly 
patients 
1   1 9 15 92 
*summative percentage of respondents agreeing or strongly agreeing 
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Table 5 – Responses relating to health professional training and evaluation research 
(N=26) 
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All health professionals working with medicines in 
the elderly should receive regular, ongoing training 
relating to medicines management 
1  1  7 17 92 
Training should focus on patient involvement in 
decision making 
1  1 2 9 13 85 
Training should focus on aspects of cultural diversity 1  2  10 13 88 
Consideration should be given to developing a 
research programme to evaluate the 
implementation of the these guidelines in the UAE 
1   1 10 14 92 
Evaluation should consider the perspectives of all 
stakeholders, including patients 
1    10 15 96 
*summative percentage of respondents agreeing or strongly agreeing 
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Table 6 – Panellists’ views of their involvement in the Delphi study (N=25) 
 
Anchor 
Statements (1) 
 
 
 
1
 
%
 (
n
) 
 2
 
%
 (
n
) 
 3
 
%
 (
n
) 
 4
 
%
 (
n
) 
5
 
%
 (
n
) 
Anchor 
Statements (5) 
Median 
(M) 
& 
Interqu
artile 
range 
(IQR)  
The information 
provided was 
sufficient to 
complete the tasks  
68  
(17) 
16  
(4) 
8 
(2) 
 
4 
(1) 
4 
(1) 
 
The information 
provided was 
insufficient to 
complete the tasks 
M    = 1 
IQR = 1 
I had sufficient 
knowledge and 
understanding of 
the subject to 
participate  
32  
(8) 
52 
(13) 
8 
(2) 
4 
(1) 
4 
(1) 
I had insufficient 
knowledge and 
understanding of 
the subject to 
participate 
M    = 2 
IQR = 1 
Completing the 
survey was time 
consuming  
 
0 
12 
 (3) 
60 
(15) 
16 
 (4) 
12 
 (3) 
Completing the 
survey was not 
time consuming 
M    = 3 
IQR = 1 
The survey was 
easy to complete 
12 
 (3) 
64 
(16) 
12  
(3) 
8 
(2) 
4 
(1) 
The survey was 
difficult to 
complete 
M    = 2 
IQR = 
0.5 
Statements were 
not at all 
threatening 
68 
 (17) 
8 
(2) 
12 
(3) 
 
0 
12 
 (3) 
Statements were 
extremely 
threatening 
M    = 1 
IQR = 
1.5 
I gained new 
knowledge from 
completing the 
survey 
20 
 (5) 
52 
(13) 
12 
 (3) 
12  
(3) 
4 
(1) 
I did not gain new 
knowledge from 
completing the 
survey 
M    = 2 
IQR = 1 
I was under no 
pressure to agree 
with the other 
panel members  
68 
 (17) 
16 
 (4) 
4 
(1) 
4 
(1) 
8 
(2) 
I felt under great 
pressure to agree 
with the other 
panel members 
M    = 1 
IQR = 1 
The Delphi was a 
very useful 
approach to 
obtaining 
consensus  
36 
 (9) 
48 
(12) 
8 
(2) 
 
0 
8 
(2) 
The Delphi was 
not very useful 
approach to 
obtaining 
consensus 
M    = 2 
IQR = 1 
The Delphi process 
met my 
expectations  
48 
 (12) 
28 
 (7) 
16 
 (4) 
4 
(1) 
4 
(1) 
The Delphi process 
did not meet my 
expectations 
M    = 2 
IQR = 
1.5 
Using the Delphi 
approach in 
developing 
medicines 
management 
guidelines was 
effective  
24 
 (6) 
60 
(15) 
8 
(2) 
4 
(1) 
4 
(1) 
Using the Delphi 
approach in 
developing 
medicines 
management 
guidelines was not 
effective 
M    = 2 
IQR = 
0.5 
Using the Delphi 
approach 
promoted 
multidisciplinary 
working 
40 
 (10) 
44 
(11) 
12 
(3) 
4 
(1) 
 
0 
Using the Delphi 
approach did not 
promote 
multidisciplinary 
working 
M    = 2 
IQR = 1 
28 
 
I will consider 
adopting the 
Delphi approach to 
future practice 
developments  
28 
 (7) 
52 
(13) 
8 
(2) 
12 
 (3) 
0 I will not consider 
adopting the 
Delphi approach to 
future practice 
developments 
M    = 2 
IQR = 1 
 
 
 
